Marienke A A M de Bruijn, Agnes van Sonderen, Marleen H van Coevorden-Hameete, Anna E M Bastiaansen, Marco W J Schreurs, Rob P W Rouhl, Cees A van Donselaar, Marian H J M Majoie, Rinze F Neuteboom, Peter A E Sillevis Smitt, Roland D Thijs, Maarten J Titulaer
OBJECTIVE: This nationwide cohort study evaluates seizure responses to immunotherapy and antiepileptic drugs (AEDs) in patients with anti-leucine-rich glioma-inactivated 1 (LGI1), anti-NMDA receptor (NMDAR), and anti-gamma-aminobutyric-acid B receptor (GABAB R) encephalitis. METHODS: Anti-LGI1, anti-NMDAR, and anti-GABAB R encephalitis patients with new-onset seizures were included. Medical information about disease course, AEDs and immunotherapies used, effects, and side effects were collected...
May 7, 2019: Neurology